Thanks Pat,
I had to ask to be told my genetic type which turned out to be high risk. I think it should be available routinely with bmb results but I have found this isn’t always the case. I understand it is an expensive test to perform, so wondering do labs have the final say. Worrying, especially when consultants specifically requests this.
I don’t think many of any hospitals in the UK personalise treatments, but studies worldwide do suggest certain treatments have shown better results for my type, and I’ve passed this onto my consultant. If we have this information then why not use it. So it seems to be between how far they can go in that direction and local practice. It did help me getting a 2nd opinion from a consultant I met on the London Infoday who was a Myeloma specialist.
Good luck again,
Janet